These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8996206)

  • 41. Intrastriatal infusion of amiloride increases rotations in 6-OHDA lesioned rats and "down-regulates" D2 receptors in the striatum and 5-HT2A receptors in the cortex.
    Jamrozik Z; De Yebenes JG; Troung DD; Cadet J
    Pol J Pharmacol; 1994; 46(5):417-22. PubMed ID: 7894528
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clearance and diffusion of locally applied dopamine in normal and 6-hydroxydopamine-lesioned rat striatum.
    van Horne C; Hoffer BJ; Strömberg I; Gerhardt GA
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1285-92. PubMed ID: 1469634
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced quinpirole response in rats lesioned neonatally with 5,7-dihydroxytryptamine.
    Brus R; Plech A; Kostrzewa RM
    Pharmacol Biochem Behav; 1995 Apr; 50(4):649-53. PubMed ID: 7617714
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Age-dependence of a 6-hydroxydopamine lesion on SKF 38393- and m-chlorophenylpiperazine-induced oral activity responses of rats.
    Kostrzewa RM; Brus R; Perry KW; Fuller RW
    Brain Res Dev Brain Res; 1993 Nov; 76(1):87-93. PubMed ID: 8306435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in striatal dopamine release and metabolism during and after subchronic haloperidol administration in rats.
    See RE; Murray CE
    Neurosci Lett; 1992 Aug; 142(1):100-4. PubMed ID: 1383895
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhanced oral activity responses to intrastriatal SKF 38393 and m-CPP are attenuated by intrastriatal mianserin in neonatal 6-OHDA-lesioned rats.
    Plech A; Brus R; Kalbfleisch JH; Kostrzewa RM
    Psychopharmacology (Berl); 1995 Jun; 119(4):466-73. PubMed ID: 7480527
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo electrochemical measurements of exogenous dopamine clearance in normal and neonatal 6-hydroxydopamine-treated rat striatum.
    Luthman J; Friedemann MN; Hoffer BJ; Gerhardt GA
    Exp Neurol; 1993 Aug; 122(2):273-82. PubMed ID: 8405264
    [TBL] [Abstract][Full Text] [Related]  

  • 48. p-Chloroamphetamine-Enhanced Neostriatal Dopamine Exocytosis in Rats Neonatally Co-lesioned with 6-OHDA and 5,7-DHT: Relevance to Parkinson's Disease.
    Kostrzewa JP; Kostrzewa RM
    Neurotox Res; 2020 Mar; 37(3):543-552. PubMed ID: 31939043
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of chronic neuroleptic treatments on dopamine D1 and D2 receptors: homogenate binding and autoradiographic studies.
    Huang N; Ase AR; Hébert C; van Gelder NM; Reader TA
    Neurochem Int; 1997 Mar; 30(3):277-90. PubMed ID: 9041559
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neonatal excitotoxic ventral hippocampal damage alters dopamine response to mild repeated stress and to chronic haloperidol.
    Lipska BK; Chrapusta SJ; Egan MF; Weinberger DR
    Synapse; 1995 Jun; 20(2):125-30. PubMed ID: 7570341
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-additivity of D2 receptor proliferation induced by dopamine denervation and chronic selective antagonist administration: evidence from quantitative autoradiography indicates a single mechanism of action.
    LaHoste GJ; Marshall JF
    Brain Res; 1989 Nov; 502(2):223-32. PubMed ID: 2531015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Carbamazepine reduces dopamine-mediated behavior in chronic neuroleptic-treated and untreated rats: implications for treatment of tardive dyskinesia and hyperdopaminergic states.
    LaHoste GJ; Wigal T; King BH; Schuck SEB; Crinella FM; Swanson JM
    Exp Clin Psychopharmacol; 2000 Feb; 8(1):125-132. PubMed ID: 10743913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative autoradiography of striatal dopamine D1, D2 and re-uptake sites in rats with vacuous chewing movements.
    Knable MB; Hyde TM; Egan MF; Tosayali M; Wyatt RJ; Kleinman JE
    Brain Res; 1994 May; 646(2):217-22. PubMed ID: 8069667
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dopamine receptor alterations correlate with increased GABA levels in adult rat neostriatum: effects of a neonatal 6-hydroxydopamine denervation.
    Molina-Holgado E; Van Gelder NM; Dewar KM; Reader TA
    Neurochem Int; 1995; 27(4-5):443-51. PubMed ID: 8845745
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of subchronic treatments with SM-9018, a novel 5-HT2 and D2 antagonist, on dopamine and 5-HT receptors in rats.
    Ohno Y; Ishibashi T; Okada K; Ishida K; Nakamura M
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Oct; 19(6):1091-101. PubMed ID: 8584685
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proposed animal model of attention deficit hyperactivity disorder.
    Kostrzewa RM; Brus R; Kalbfleisch JH; Perry KW; Fuller RW
    Brain Res Bull; 1994; 34(2):161-7. PubMed ID: 7913871
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Modulation by desensitized nicotinic receptors on metabolism of DA in striatum derived from the hemiparkinsonian model].
    Fu-Rong H; Hai W
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2016 Jun; 32(6):487-493. PubMed ID: 29926613
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ultrastructural correlates of haloperidol-induced oral dyskinesias in rat striatum.
    Roberts RC; Gaither LA; Gao XM; Kashyap SM; Tamminga CA
    Synapse; 1995 Jul; 20(3):234-43. PubMed ID: 7570355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A comparative study of the neurochemical profiles of remoxipride, raclopride and metoclopramide activity].
    Gaĭnetdinov RR; Bogdanov MB; Kudrin VS; Budygin EA; Kovalev GI; Raevskiĭ KS
    Biull Eksp Biol Med; 1992 Jul; 114(8):165-8. PubMed ID: 1467481
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential effects of within-day continuous vs. transient dopamine D2 receptor occupancy in the development of vacuous chewing movements (VCMs) in rats.
    Turrone P; Remington G; Kapur S; Nobrega JN
    Neuropsychopharmacology; 2003 Aug; 28(8):1433-9. PubMed ID: 12838271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.